A major trial into the prevention of peanut allergies among
children has begun in the UK as part of a study that could result
in a new, younger generation of nut product consumers.
Scientists have identified a new gene in peanuts that codes for a
protein with no apparent allergic effects, research that opens up
the possibility of allergen-free GM nuts.
Healthy snacks are poised for significant growth, especially in the
niche seeds sector with sales expected to almost double over the
next five years to hit £39m (€58m) according to a new report.